Market Access Consulting
Interim and long-term contracts
"Market access serves as the critical link between groundbreaking science and real world patient outcomes, ensuring that life-changing medicines not only gain approval but also reach those who need them most, at the right time, with the right value, and at the right price."
Services
We provide a wide range of specialised services designed to cater specifically to your unique needs. By prioritising a deep understanding of your requirements, we deliver practical and effective solutions that truly work for you.
Market Access
Market Access Formulary Application Process
1. Identify & Engage Key Decision Makers
Map stakeholders who influence formulary inclusion:
Trust pharmacists
ICB formulary pharmacists
Clinical leads within trusts
External key opinion leaders (KOLs)
Consultant, department Pharmacist, nurse specialist, etc.
Establish early dialogue to understand priorities and evidence requirements.
2. Cross-Functional Internal Collaboration
Align in-house teams to ensure consistent messaging and evidence delivery:
Medical Affairs – provide clinical data and real-world evidence
MSLs (Medical Science Liaisons) – engage clinicians and support scientific exchange
Marketing & Sales – tailor value communication to payer and provider needs,
Build Tools – Value Proposition, Budget impact model, cost calculator.
Cross-functional Working – Develop a cohesive strategy that seamlessly integrates scientific credibility with business goals.
3. Trust & ICB Engagement
Work directly with trust and ICB formulary pharmacists to prepare robust applications.
Collaborate with clinical leads to demonstrate unmet need, patient benefit, and cost-effectiveness.
Ensure submissions align with local commissioning priorities.
4. Patient Group Involvement
Engage patient advocacy groups to highlight lived experience and unmet needs.
Incorporate patient perspectives into value dossiers and formulary submissions.
Use patient stories to strengthen the case for access.
5. Specialist & Rare Disease Pathways
For specialist or rare disease drugs:
Partner with local trusts that have expertise in the condition.
Build collaborative networks to support adoption and share best practice.
Highlight innovation and address equity of access across regions.
6. Leverage Regional & International Evidence
Use KOLs from England and other regions to reinforce credibility.
Reference approvals and outcomes from Scotland, Europe, or global markets where the drug is already accepted.
Position the therapy as validated internationally while tailoring to local payer needs.
Continuous Review
Monitor formulary decisions and feedback.
Adapt strategy based on evolving payer requirements, clinical guidelines, and patient input.
Maintain long-term relationships with stakeholders to support sustained access.
We offer a range of specialised services tailored to meet your individual needs.